Dr. Jean M. Weaver, MD

Dr. Weaver practices at Penn State Health Milton S. Hershey Medical Center in Hershey, Pennsylvania, part of Penn State.

Dr. Weaver's NPI, 1457353591, was assigned on August 10, 2005. Dr. Weaver holds Indiana license 01079950A.

Dr. Weaver's primary practice is Penn State Health Milton S. Hershey Medical Center, at 500 University Drive, Hershey, PA 17033 in Dauphin County. The practice phone is (717) 531-8521.

Dr. Weaver's primary practice is Penn State Health Milton S. Hershey Medical Center in Hershey, Pennsylvania, part of Penn State. The medical group on file is St. Luke's South Mountain Family Practice. Dmand AI also links Dr. Weaver to 6 more medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Weaver practices. Vendor and product names are available with a free account.

Pulmonary disease is Dr. Weaver's primary specialty in the NPI Registry, under taxonomy code 207RP1001X. Dmand AI has Dr. Weaver's licenses on file in 2 states: Indiana and Pennsylvania.

CMS data shows 192 Medicare services from Dr. Weaver across 2 procedure codes in 2024, for 194 Medicare patients. Medicare paid $23,767 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 194 Medicare patients who saw Dr. Weaver in 2024. The largest group is 75 to 84, with 59 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 18% are also on Medicaid. Their average risk score is 2.64, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Weaver's median patient age at 76, with 53% women.

In 2020, Dr. Weaver wrote 111 Medicare Part D claims. They cover 4 drugs, with $50,654 in total drug cost. In 2019, CMS named 364 claims across 13 drugs.

Dr. Weaver accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 18 general payments to Dr. Weaver from 6 drug and device companies from 2016 to 2021. Food and beverage make up the largest share, 97% of the total. GlaxoSmithKline, LLC. paid the most, $217.